Your browser doesn't support javascript.
loading
The frequency of sarcopenia has increased in patients with glomerulonephritis.
Isiktas, Okay; Guzel, Fatma Betul; Ozturk, Ilyas; Topal, Kenan; Sahin, Murat; Altunoren, Orcun; Gungor, Ozkan.
Afiliación
  • Isiktas O; Department of Internal Medicine, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
  • Guzel FB; Department of Nephrology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
  • Ozturk I; Department of Nephrology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
  • Topal K; Adana City Training and Research Hospital, Department of Family Medicine, Health Sciences University, Adana, Turkey.
  • Sahin M; Department of Endocrinology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
  • Altunoren O; Department of Nephrology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
  • Gungor O; Department of Nephrology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
Nephrology (Carlton) ; 28(7): 399-407, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37148150
ABSTRACT

AIM:

Sarcopenia is defined as the loss of muscle mass and muscle strength, and its frequency increases in kidney patients. However, sarcopenia frequency in patients with glomerulonephritis is unknown. The present study aimed to investigate the frequency of sarcopenia in patients with glomerulonephritis and compare the results with the healthy population for the first time in the literature. PATIENTS AND

METHODS:

A total of 110 participants, including 70 patients previously diagnosed with glomerulonephritis and 40 healthy individuals, were included in the study. The diagnosis of sarcopenia was made based on the EWSGOP 2 Criteria.

RESULTS:

The mean age of the glomerulonephritis patients group was 39.3 ± 1.5. In the anthropometric measurements of the patients, walking speed was low in 50 patients (71.4%), muscle strength was decreased in 44 patients (62.9%), and sarcopenia was detected in 10 patients (14.3%) according to the EWGSOP 2 Criteria. Considering the anthropometric measurements of the control group, sarcopenia was not detected in any of the subjects according to the EWGSOP 2 Criteria.

CONCLUSION:

The result of the present study revealed that the rate of sarcopenia was significantly higher in glomerulonephritis patients compared to the healthy population and that sarcopenia can also be observed even in middle age in this population. We think it would be beneficial for clinicians treating glomerulonephritis to be more careful regarding sarcopenia and keep these parameters in mind during treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sarcopenia / Glomerulonefritis Tipo de estudio: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Nephrology (Carlton) Asunto de la revista: NEFROLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sarcopenia / Glomerulonefritis Tipo de estudio: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Nephrology (Carlton) Asunto de la revista: NEFROLOGIA Año: 2023 Tipo del documento: Article